Vitamin K Antagonists: Essential Guide to Uses, Risks, and Monitoring
By Kevin Garcia
AD
Your quota is exhausted.
API key status: exceeded
Name: PCTB8QC8QS7ST
Quota: 0/3200000000 tokens (0.0%)
exp_date: 2026-10-17T14:27:58.134Z
Structural features of the kringle domain determine the intracellular degradation of under-γ-carboxylated prothrombin: Studies of chimeric rat/human prothrombin | PNASDabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation | CirculationVitamin K (carboxylation..glutamate...posttranslation protein modification), blood clotting Catechin Molecular Structure Diagram, Vitamin K2 Foods, Ribosome Protein Synthesis Diagram, Vitamin Chemical Name, Biochemistry Digestion And Lipoproteins Diagram, Catechin Chemical Formula, Protein Synthesis Genetic Code Chart, Laminin Protein Structure Diagram, Cytochrome C StructureWarfarin Pharmacology: Mechanism, Vitamin K, INR & AntidoteVitamin K antagonists and Heparin – origin, structure, and mechanism of actionCRN updates vitamin K2 MK-7 intake limitsVitamin K – phylloquinone – rich foods - ECstepVitamin KNon–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation | StrokeVitamin K-dependent carboxylation of the carboxylase | PNASEffectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation | StrokeNon–Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial FibrillationWarfarin (Vitamin K Inhibitor) - Uses, Mechanism, Side Effects & RisksVitamin kNew Oral AnticoagulantsOral Direct Factor Xa Inhibitors | Circulation Research